BioSpace News Archive

Business

Servier and MiNA Partner to Create Entirely New Class of Drugs

Servier and MiNA Therapeutics are partnering on small activating RNA (saRNA) therapies to treat neurological diseases. saRNA is an entirely new class of drugs.

January 21, 2021
·
3 min read
·
Mark Terry
Business

BioSpace Movers & Shakers, Jan. 22

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

January 21, 2021
·
11 min read
·
Alex Keown
Policy

Genentech Earns Priority Review for Lung Disease Drug Esbriet Following Positive Clinical Data

The U.S. FDA has accepted Genentech’s supplemental New Drug Application and has granted Priority Review for the company’s unclassifiable interstitial lung disease (UILD) treatment Esbriet® (pirfenidone).

January 21, 2021
·
3 min read
·
Brandon May
Drug Development

Avidity Prepares to Transition into Clinical Company in 2021

California-based Avidity Biosciences has a goal of disrupting the way RNA-based therapies are delivered to patients through its Antibody-Oligonucleotide Conjugates (AOCs) platform.

January 21, 2021
·
3 min read
·
Alex Keown
Business

BIO Shakes Things Up to Align Leadership with New Vision

Less than a year after taking over the reins, Biotechnology Innovation Organization Chief Executive Officer Michelle McMurry-Heath is reorganizing the organization’s leadership structure.

January 21, 2021
·
2 min read
·
Alex Keown
Drug Development

Further Studies Show Conflicting Results of Arthritis Drug for Severe COVID-19

The jury is still out on whether Roche’s arthritis drug, Actemra/RoActemra (tocilizumab), is helpful for the most severe cases of COVID-19.

January 21, 2021
·
3 min read
·
Mark Terry
BioMidwest

Research Roundup: Blood Test for Severe COVID-19 and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

January 21, 2021
·
5 min read
·
Mark Terry
Drug Development

Merck KGaA Discontinues Trial of Cancer Drug Co-Developed With GSK

The decision was made based on an Independent Data Monitoring Committee recommendation which indicated the study was unlikely to meet its specified primary efficacy endpoint of progression-free survival.

January 21, 2021
·
3 min read
·
Brandon May
Business

Biden Launches 10 Health-Focused Executive Orders on First Day in Office

Hours after being sworn in as the 46th President of the United States, Joe Biden signed 10 executive orders that are aimed at combating the ongoing COVID-19 crisis.

January 21, 2021
·
2 min read
·
Alex Keown
Biotech In-Demand Jobs: Project Managers

Project managers in the biotech industry play an especially important role on a daily basis.

January 21, 2021
·
3 min read
·
Kymberlie Krieger